Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 2/3 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 127INDUSTRY 51OTHER_GOV 6NETWORK 5UNKNOWN 4NIH 4

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 6Breast 5Thoracic 4Sarcoma 3Gynecologic 2Genitourinary 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 5Neoplasm Metastasis 1

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Vinorelbine × Breast × Clear all
NCT02954055 2024-02-26

METEORA-II

ETOP IBCSG Partners Foundation

Phase 2 Completed
140 enrolled 11 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00041067 2013-06-06

S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

SWOG Cancer Research Network

Phase 2 Completed
76 enrolled 6 charts
Breast

Breast Neoplasms

NCT00015938 2013-01-24

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

SWOG Cancer Research Network

Phase 2 Completed
95 enrolled
Breast

Breast Neoplasms

NCT00049660 2012-07-18

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
47 enrolled
Breast

Breast Neoplasms

NCT00003730 2012-07-02

Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase NA Completed
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡